Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Brain regions show different metabolic and protein arginine methylation phenotypes in frontotemporal dementias and Alzheimer's disease.

Progress in neurobiology - 1 Feb 2023

Zhang Fangrong, Rakhimbekova Anastasia, Lashley Tammaryn, Madl Tobias

Abstract excerpt

Frontotemporal dementia (FTD) is a heterogeneous neurodegenerative disease with multiple histopathological subtypes. FTD patients share similar symptoms with Alzheimer's disease (AD). Hence, FTD patients are commonly misdiagnosed as AD, despite the consensus clinical diagnostic criteria. It is therefore of great clinical need to identify a biomarker that can distinguish FTD from AD and control individuals, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Biomarkers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Epigenetics and DNA Methylation

Share to Frontotemporal Dementia

Share to Methylation

Share to Neurodegenerative Diseases

Share to Phenotype

Source

Identifiers

PMID: 36581185
DOI: 10.1016/j.pneurobio.2022.102400

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Brain regions show different metabolic and protein arginine methylation phenotypes in frontotemporal dementias and Alzheimer's disease.PMID 36581185Read ↗

Metabolomic changes associated with frontotemporal lobar degeneration syndromesSemantic proximity Read ↗

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer disease brainsSemantic proximity Read ↗

Alteration of Metabolic Profile During the Progression of Alzheimer’s DiseaseSemantic proximity Read ↗

Differences in Plasma Metabolites Related to Alzheimer’s Disease, APOE-ε4 status and EthnicitySemantic proximity Read ↗

Neuronal subtype-specific metabolic changes in neurodegenerative and neuropsychiatric diseases predicted via a systems biology-based approachSemantic proximity Read ↗

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains.Semantic proximity Read ↗

Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.Semantic proximity Read ↗

Metabolic Trans-Omic Analysis Reveals Key Regulatory Disruption of Energy Metabolism in Alzheimer’s DiseaseSemantic proximity Read ↗

Recent advances in the application of metabolomics to Alzheimer's DiseaseSemantic proximity Read ↗

Cell type-specific master metabolic regulators of Alzheimer’s diseaseSemantic proximity Read ↗

Phenotype-specific metabolic patterns in Posterior cortical atrophy and early-onset typical Alzheimer’s diseaseSemantic proximity Read ↗

Identifying neuron subtype-specific metabolic network changes in single cell transcriptomics of Alzheimer’s Disease using perturb-MetSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.